Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study-Reference-Cited by-同舟云学术

Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study

Published:2014-07 Issue:1 Volume:171 Page:155-161
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Buysschaert M.¹,Baeck M.²³,Preumont V.¹,Marot L.²³,Hendrickx E.⁴⁵,Van Belle A.⁴⁵,Dumoutier L.⁴⁵

Affiliation:

1. Department of Endocrinology and Nutrition; Avenue Hippocrate 10 B-1200 Brussels Belgium

2. Department of Dermatology, Cliniques Universitaires Saint-Luc; Avenue Hippocrate 10 B-1200 Brussels Belgium

3. Pôle Pneumologie; ORL et Dermatologie Institut de Recherche Expérimentale et Clinique (IREC); B-1200 Brussels Belgium

4. de Duve Institute, Université Catholique de Louvain; B-1200 Brussels Belgium

5. Ludwig Institute for Cancer Research; B-1200 Brussels Belgium

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12886/fullpdf

Reference32 articles.

1. Psoriasis;Schon;N Engl J Med,2005

2. Psoriasis;Nestle;N Engl J Med,2009

3. Th17 response and inflammatory autoimmune diseases;Waite;Int J Inflam,2012

4. Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis;Kanai;Acta Derm Venereol,2012

5. Dermal γδ T cells - a new player in the pathogenesis of psoriasis;Cai;Int Immunopharmacol,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wirksamkeit von Glucagon‐like Peptide‐1‐Rezeptor‐Agonisten bei Psoriasis: Eine aktualisierte systematische Übersicht und Metaanalyse;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08

2. Molecular mechanisms and drug therapy of metabolism disorders in psoriasis;Journal of Dermatological Treatment;2024-07-16

3. Efficacy of glucagon‐like peptide‐1 receptor agonists for psoriasis: An updated systematic review and meta‐analysis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06-02

4. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule;Cell Metabolism;2024-06

5. Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology;Rheumatology Science and Practice;2024-04-28